BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
MorphoSys AG Reports Six Months 2009 Results
-
MorphoSys and the University of Melbourne File New Patent Applications in MOR103 Program
News & Analysis
Filter by
biotechnology and university of melbourne - All News and Analysis
Project deals blow to flies.
Jun 22, 2005 (The Weekly Times - ABIX via COMTEX) Australian Wool Innovation Limited awarded a $A1.4 million grant to a project to sequence the genome of the Australian sheep blowfly. The project will be led by the University of Melbourne. Its aim is...
Blood-clot drug offers new heart.(Brief Article)
Apr 17, 2005 (Herald Sun - ABIX via COMTEX) A new drug to stop blood clots is being developed in Australia and the UK. The Melbourne-based biotechnology group, Cerylid Biosciences, has the commercial rights to the drug. The drug is being tested at the ...
Innovation up but still low by world standards.
Jan 20, 2003 (The Australian Financial Review - ABIX via COMTEX) Listed biotechnology company Cochlear has been rated Australia's most innovative company for fiscal 2001. It spent $A27.7m on R&D in the 2000-2001 financial year. It also registered five new designs and 21 new...
States vie for attention at biotechnology gathering.
Jun 10, 2002 The Australian Financial Review ABIX via COMTEX -- Many Australian States are vying to become the country's biotechnology leader. Most State premiers are to attend the BIO 2002 event, a four-day conference in Toronto, Canada, that is expected to attract as...
Fat off the land.
Apr 11, 2002 BRW ABIX via COMTEX -- Metabolic Pharmaceuticals listed on the Australian sharemarket in 1998. The Australian biotechnology firm has raised $A18m between that time and 2002. A further capital raising is planned for 2002 or beyond. Circadian Technologies spun off the...
Unis sow early seeds of success.
Aug 28, 2001 The Age ABIX via COMTEX -- Two Australian universities have set up a business unit called Uniseed to provide capital for research work. Uniseed's CEO, David Evans, said the pre-seed capital provided will take the project, an idea or a patent,...
Going retro.
Aug 14, 2001 The Age ABIX via COMTEX -- University of Melbourne researcher, Pierre Scotney, is developing a gene therapy for heart disease. Scotney is unravelling the structure of the vascular endothelial growth factor (VEGF-B) protein by nuclear magnetic resonance and x-ray protein ...
Prescription for a healthy life.
Aug 5, 2001 Sunday Herald Sun ABIX via COMTEX -- The Victorian Government is attempting to make the state a leader in biotechnology during August 2001. John Brumby, State and Regional Development Minister, claims that Victoria is set to become one of the...
- 1


